NEW FDA APPROVAL: THE HIGHEST UVA & UVB PROTECTION IN A SUNSCREEN WITH
NEW YORK, April 18 /PRNewswire/ -- La Roche-Posay, the brand recommended by 25,000 dermatologists worldwide, announces the FDA approval of ANTHELIOS 40 with the highest photostable UVA and UVB protection available in a sunscreen with Mexoryl(TM) SX. ANTHELIOS 40 Sunscreen is a revolutionary outdoor use sunscreen for the face and body, specifically tested for safety on those with the photosensitive skin disorder, Polymorphous Light Eruption (PMLE).
Photosensitivity is a pervasive issue for people suffering from a variety of photosensitive conditions including, but not limited to, PMLE, Photoallergic Eruption (sun allergies), Phototoxicity, Solar Uticaria (sun rashes) and autoimmune disease. In fact, it is estimated that up to 17% of the US population alone experience symptoms related to PMLE as a result of UV (primarily UVA) exposure(1). These figures are likely understated as many potential patients do not seek treatment for proper diagnosis. In approximately 50% of those affected, the action spectrum is actually UVA rays(2).
UVA rays penetrate deeper than UVB rays and can result in significant
skin damage ranging from premature skin aging to skin cancer. It is
therefore essential to protect oneself against these harmful rays,
especially for those that are more susceptible to the risks associated with
UV exposure as a result of photosensitive disorders or autoimmune disease.
Proper broad spectrum photo-protection that is effective and safe is an
indispensable tool to help manage these very real dangers. According to Dr.
Vincent Deleo (board certified New York - Los Angeles based dermatologist),
"UV exposure and its related risks are a big concern in my own practice
where I see many patients who are photosensitive either because of the
drugs they take, skin type or even an autoimmune disease. They absolutely
|SOURCE La Roche-Posay|
Copyright©2008 PR Newswire.
All rights reserved